US 7220719
Modulation of endogenous gene expression in cells
granted A61KA61K48/00A61K48/005
Quick answer
US patent 7220719 (Modulation of endogenous gene expression in cells) held by Sangamo Biosciences, Inc. expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K48/00, A61K48/005, A61P, A61P11/00